Half-Life Extension through O-Glycosylation

Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges

Volumn , Issue , 2013, Pages 201-209

  Fares, Fuad ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Chimeric genes; Expression vectors; FSH human GH; Half life extension; O linked oligosaccharide

Indexed keywords

EID: 84886196226     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118354599.ch13     Document Type: Chapter

References (32)

1. Copeland RJ, Bullen JW, Hart GW. (2008) Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295(1), E17-E28.
2. Wopereis S, Lefeber DJ, Morava E, Wevers RA. (2006) Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. Clin. Chem. 52(4), 574-600.
3. Yki-Järvinen H, Vogt C, Iozzo P, Pipek R, Daniels MC, Virkamäki A, et al. (1997) UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues. Diabetologia 40(1), 76-81.
4. Zachara NE, Hart GW. (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta 1673(1,2), 13-28.
5. Fares F. (2006) The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim. Biophys. Acta 1760(4), 560-567.
6. Matzuk MM, Hsueh AJ, Lapolt P, Tsafriri A, Keene JL, Boime I. (1990) The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] betasubunit. Endocrinology 126(1), 376-383.
7. Matzuk MM, Krieger M, Corless CL, Boime I. (1987) Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 84(18), 6354-6358.
8. Kalyan NK, Bahl OP. (1983) Role of carbohydrate in human chorionic gonadotropin. Effect of deglycosylation on the subunit interaction and on its in vitro and in vivo biological properties. J. Biol. Chem. 258(1), 67-74.
9. Sowers JR, Pekary AE, Hershman JM, Kanter M, DiStefano JJIII. (1979) Metabolism of exogenous human chorionic gonadotrophin in men. J. Endocrinol. 80(1), 83-89.
10. Van Den Hamer CJ, Morell AG, Scheinberg IH, Hickman J, Ashwell G. (1970) Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. J. Biol. Chem. 245(17), 4397-4402.
11. Wide L. (1986) The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone. Acta Endocrinol. 112(3), 336-344.
12. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. (1971) The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. 246(5), 1461-1467.
13. Briggs DW, Fisher JW, George WJ. (1974) Hepatic clearance of intact and desialylated erythropoietin. Am. J. Physiol. 227(6), 1385-1388.
14. Ashwell G, Kawasaki T. (1978) A protein from mammalian liver that specifically binds galactose-terminated glycoproteins. Meth. Enzymol. 50, 287-288.
15. Yik JHN, Saxena A, Weigel JA, Weigel PH. (2002) Nonpalmitoylated human asialoglycoprotein receptors recycle constitutively but are defective in coated pit-mediated endocytosis, dissociation, and delivery of ligand to lysosomes. J. Biol. Chem. 277(43), 40844-40852.
16. Fares FA, Suganuma N, Nishimori K, LaPolt PS, Hsueh AJ, Boime I. (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc. Natl. Acad. Sci. USA 89(10), 4304-4308.
17. LaPolt PS, Nishimori K, Fares FA, Perlas E, Boime I, Hsueh AJ. (1992) Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology 131(6), 2514-2520.
18. Bouloux PM, Handelsman DJ, Jockenhövel F, Nieschlag E, Rabinovici J, Frasa WL, et al. (2001) First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum. Reprod. 16(8), 1592-1597.
19. Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM. (2004) Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J. Clin. Endocrinol. Metab. 89(5), 2062-2070.
20. Abyholm T, Andersen A, Balen A, Braat D, Devroey P, D'Hooghe T, et al. (2008) A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum. Reprod. 23(11), 2484-2492.
21. Joshi L, Murata Y, Wondisford FE, Szkudlinski MW, Desai R, Weintraub BD. (1995) Recombinant thyrotropin containing a beta-subunit chimera with the human chorionic gonadotropin-beta carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance. Endocrinology 136(9), 3839-3848.
22. Fares FA, Yamabe S, Ben-Menahem D, Pixley M, Hsueh AJ, Boime I. (1998) Conversion of thyrotropin heterodimer to a biologically active single-chain. Endocrinology 139(5), 2459-2464.
23. Grossmann M, Wong R, Szkudlinski MW, Weintraub BD. (1997) Human thyroid-stimulating hormone (hTSH) subunit gene fusion produces hTSH with increased stability and serum half-life and compensates for mutagenesis-induced defects in subunit association. J. Biol. Chem. 272(34), 21312-21316.
24. Fares F, Ganem S, Hajouj T, Agai E. (2007) Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin. Endocrinology 148(10), 5081-5087.
25. Egrie JC, Browne JK. (2001) Development and characterization of novel erythropoiesis stimulating protein (NESP). Br. J. Cancer 84(Suppl. 1), 3-10.
26. Nissenson AR. (2001) Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease. Am. J. Kidney Dis. 38(6), 1390-1397.
27. Higuchi M, Oh-eda M, Kuboniwa H, Tomonoh K, Shimonaka Y, Ochi N. (1992) Role of sugar chains in the expression of the biological activity of human erythropoietin. J. Biol. Chem. 267(11), 7703-7709.
28. Raben MS. (1958) Treatment of a pituitary dwarf with human growth hormone. J. Clin. Endocrinol. Metab. 18(8), 901-903.
29. de Boer H, Blok GJ, Van der Veen EA. (1995) Clinical aspects of growth hormone deficiency in adults. Endocr. Rev. 16(1), 63-86.
30. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, et al. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83(2), 382-395.
31. Drake WM, Howell SJ, Monson JP, Shalet SM. (2001) Optimizing GH therapy in adults and children. Endocr. Rev. 22(4), 425-450.
32. Fares F, Guy R, Bar-Ilan A, Felikman Y, Fima E. (2010) Designing a long-acting human growth hormone (hGH) by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of hGH. Endocrinology 151(9), 4410-4417.